End-of-day quote
Shanghai S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
12.02
CNY
|
-4.15%
|
|
-2.91%
|
-15.41%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,585
|
3,018
|
3,417
|
3,822
|
4,443
|
2,974
|
Enterprise Value (EV)
1 |
1,997
|
2,305
|
2,593
|
3,118
|
3,637
|
2,282
|
P/E ratio
|
12.9
x
|
13.7
x
|
13.8
x
|
22
x
|
11.1
x
|
92.2
x
|
Yield
|
3.96%
|
3.39%
|
2.99%
|
2.68%
|
3.68%
|
1.97%
|
Capitalization / Revenue
|
1.27
x
|
1.34
x
|
1.41
x
|
1.27
x
|
1.24
x
|
0.99
x
|
EV / Revenue
|
0.98
x
|
1.02
x
|
1.07
x
|
1.04
x
|
1.01
x
|
0.76
x
|
EV / EBITDA
|
6.82
x
|
7.12
x
|
6.93
x
|
12.7
x
|
7.3
x
|
17.4
x
|
EV / FCF
|
12.5
x
|
13.6
x
|
14.4
x
|
-1,058
x
|
23
x
|
14
x
|
FCF Yield
|
7.97%
|
7.33%
|
6.94%
|
-0.09%
|
4.35%
|
7.15%
|
Price to Book
|
1.79
x
|
1.92
x
|
2.01
x
|
2.14
x
|
2.12
x
|
1.49
x
|
Nbr of stocks (in thousands)
|
204,480
|
204,480
|
204,480
|
204,480
|
204,480
|
209,315
|
Reference price
2 |
12.64
|
14.76
|
16.71
|
18.69
|
21.73
|
14.21
|
Announcement Date
|
4/17/19
|
4/17/20
|
4/28/21
|
4/19/22
|
4/17/23
|
4/24/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,028
|
2,258
|
2,424
|
2,999
|
3,590
|
3,008
|
EBITDA
1 |
293
|
323.8
|
374.4
|
244.9
|
497.9
|
131.3
|
EBIT
1 |
209.7
|
241.3
|
295.1
|
169.6
|
436.6
|
33
|
Operating Margin
|
10.34%
|
10.69%
|
12.17%
|
5.65%
|
12.16%
|
1.1%
|
Earnings before Tax (EBT)
1 |
234
|
259.5
|
295.4
|
201.7
|
468.6
|
49.71
|
Net income
1 |
200.9
|
221
|
247.6
|
174.1
|
401.5
|
32.7
|
Net margin
|
9.9%
|
9.79%
|
10.21%
|
5.8%
|
11.18%
|
1.09%
|
EPS
2 |
0.9800
|
1.080
|
1.210
|
0.8512
|
1.964
|
0.1541
|
Free Cash Flow
1 |
159.3
|
168.9
|
179.9
|
-2.946
|
158.2
|
163.1
|
FCF margin
|
7.85%
|
7.48%
|
7.42%
|
-0.1%
|
4.41%
|
5.42%
|
FCF Conversion (EBITDA)
|
54.36%
|
52.16%
|
48.05%
|
-
|
31.77%
|
124.22%
|
FCF Conversion (Net income)
|
79.3%
|
76.43%
|
72.66%
|
-
|
39.4%
|
498.74%
|
Dividend per Share
2 |
0.5000
|
0.5000
|
0.5000
|
0.5000
|
0.8000
|
0.2800
|
Announcement Date
|
4/17/19
|
4/17/20
|
4/28/21
|
4/19/22
|
4/17/23
|
4/24/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
587
|
713
|
824
|
703
|
807
|
692
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
159
|
169
|
180
|
-2.95
|
158
|
163
|
ROE (net income / shareholders' equity)
|
14.5%
|
14.6%
|
15.1%
|
9.97%
|
20.7%
|
1.64%
|
ROA (Net income/ Total Assets)
|
6.94%
|
7.44%
|
8.23%
|
4.09%
|
9.16%
|
0.61%
|
Assets
1 |
2,894
|
2,972
|
3,010
|
4,252
|
4,381
|
5,326
|
Book Value Per Share
2 |
7.070
|
7.700
|
8.330
|
8.750
|
10.20
|
9.530
|
Cash Flow per Share
2 |
2.500
|
2.530
|
4.380
|
1.380
|
4.050
|
4.280
|
Capex
1 |
19.2
|
46.9
|
93.1
|
191
|
101
|
45.2
|
Capex / Sales
|
0.95%
|
2.08%
|
3.84%
|
6.38%
|
2.81%
|
1.5%
|
Announcement Date
|
4/17/19
|
4/17/20
|
4/28/21
|
4/19/22
|
4/17/23
|
4/24/24
|
|
1st Jan change
|
Capi.
|
---|
| -15.41% | 348M | | +14.70% | 64.97B | | -1.61% | 47.76B | | +14.58% | 40.72B | | +20.84% | 26.88B | | +9.54% | 19.29B | | +1.16% | 17.53B | | -21.87% | 16.03B | | +1.11% | 15.17B | | -11.34% | 15.06B |
Other Specialty Chemicals
|